Filtered By:
Therapy: Cancer Therapy
Countries: Spain Health
This page shows you your search results in order of date.
Order by Relevance | Date
Total 46 results found since Jan 2013.
Impact of systemic cancer treatment on quality of life and mental well-being: a comparative analysis of patients with localized and advanced cancer
CONCLUSION: In conclusion, our study highlights that systemic cancer treatment can improve quality of life in patients with advanced cancer, while adjuvant treatments for localized disease may have a negative impact on quality of life and psychological well-being. Therefore, treatment decisions should be carefully evaluated on an individual basis.PMID:37247131 | DOI:10.1007/s12094-023-03214-5
Source: Clinical Breast Cancer - May 29, 2023 Category: Cancer & Oncology Authors: Ad án Rodríguez-Gonzalez Alberto Carmona-Bayonas Raquel Hernandez San Gil Patricia Cruz-Castellanos M ónica Antoñanzas-Basa David Lorente-Estelles Mar ía Jose Corral Manuel Gonz ález-Moya Oscar Alfredo Castillo-Trujillo Emilio Esteban Paula Jim éne Source Type: research
Hyperthermic Mitomycin C in Intermediate-risk Non-muscle-invasive Bladder Cancer: Results of the HIVEC-1 Trial
CONCLUSIONS: Four-month adjuvant hyperthermic MMC using the COMBAT system for 30 and 60 min in IR-NMIBC is well tolerated, but we did not find it to be superior to normothermic MMC at 24 mo.PATIENT SUMMARY: We were unable to demonstrate the effectiveness of hyperthermia using the COMBAT system in intermediate-risk non-muscle-invasive bladder cancer. Further evaluation of long-term recurrence and progression, and maintenance regimens appears mandatory.PMID:36435738 | DOI:10.1016/j.euo.2022.10.008
Source: Cancer Control - November 26, 2022 Category: Cancer & Oncology Authors: Javier C Angulo Jos é L Álvarez-Ossorio Jos é L Domínguez Jos é L Moyano Alejandro Sousa Jes ús M Fernández Francisco G ómez-Veiga Miguel Unda Joaqu ín Carballido Victor Carrero Tom ás Fernandez-Aparicio Ángel García de Jalón Eduardo Solsona Source Type: research
Physician- and patient-reported symptom concordance and association with quality of life in hepatocellular carcinoma
Conclusion: Further studies should investigate how symptom-reporting discordance influences patient satisfaction and HRQoL.PMID:36377818 | DOI:10.2217/fon-2022-0202
Source: Pain Physician - November 15, 2022 Category: Anesthesiology Authors: Andrea Leith Urpo Kiiskinen Allicia C Girvan Min-Hua Jen Keerun Khela Alex Rider Lucy Massey James Piercy Source Type: research
Family functioning and psychosocial symptoms among Latinx patients coping with advanced cancer
Palliat Support Care. 2022 Sep 13:1-4. doi: 10.1017/S1478951522001201. Online ahead of print.ABSTRACTOBJECTIVES: This brief report aims to describe and determine the association of family functioning (e.g., cohesion and expressiveness) with psychosocial needs among Spanish Latinx patients coping with advanced cancers.METHODS: Descriptive and correlation analyses were performed on data from 103 patients coping with advanced cancer (Stages III and IV). The measures used were the Family Relationships Index, the Hospital Anxiety and Depression Scale, and the Functional Assessment of Cancer Therapy: General.RESULTS: Results ind...
Source: Palliative and Supportive Care - September 13, 2022 Category: Palliative Care Authors: Normarie Torres-Blasco Eida M Castro-Figueroa Carolina Zamore Maria Claros Cristina Pe ña-Vargas Lianel Rosario Gabriella Sanabria William Breitbart Rosario Costas-Mu ñiz Source Type: research
Bone loss induced by cancer treatments in breast and prostate cancer patients
Clin Transl Oncol. 2022 Jul 2. doi: 10.1007/s12094-022-02872-1. Online ahead of print.ABSTRACTCancer and cancer therapies are a major factor risk for osteoporosis due to bone loss and deterioration of bone microarchitecture. Both factors contribute to a decrease in bone strength and, consequently, increased bone fragility and risk of fracture. Cancer-associated bone loss is a multifactorial process, and optimal interdisciplinary management of skeletal health, accurate assessment of bone density, and early diagnosis are essential when making decisions aimed at reducing bone loss and fracture risk in patients who have receiv...
Source: Clinical Prostate Cancer - July 2, 2022 Category: Cancer & Oncology Authors: Santos Casta ñeda Ana Casas Ar ánzazu González-Del-Alba Guillermo Mart ínez-Díaz-Guerra Xavier Nogu és Cristina Ojeda Thies Óscar Torregrosa Suau Álvaro Rodríguez-Lescure Source Type: research
